Page 7 - Progress Towards News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The JCPOA’s Joint Commission met in Vienna for its 18 th meeting since the nuclear accord’s implementation in 2016. The Joint Commission is composed of the participant states in the JCPOA, which includes Iran and the “P4+1” (the UK, France, Germany, Russia, and China). Joint Commission meetings are chaired by the EU. For the first time since the U.S.’s withdrawal from the JCPOA, a U.S. diplomatic delegation was present at the sidelines of the Joint Commission meeting in Vienna. Iran has said it will not engage in direct negotiations with the U.S. on both sides returning to complian...

Karyopharm Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Company Progress -- Commercial Launch of XPOVIO® (selinexor) In Expanded Multiple Myeloma Indication Fully Underway Following December 18, 2020 FDA Approval -- -- XPOVIO Net Product Sales of $20.2 Million for Fourth Quarter 2020 and $76.2 Million for the Year 2020; Total Revenues of $35.1 Million for the Fourth Quarter 2020 and $108.1 Million for the Year 2020 -- -- Positive CHMP Opinion for NEXPOVIO® (selinexor) in Penta-Refractory Multiple Myeloma Issued; European Commission Decision Expected by A...